{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:33:19Z","timestamp":1793622799082,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nrleng.2026.501924","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:34:08Z","timestamp":1777116848000},"page":"501924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion"],"prefix":"10.1016","volume":"41","author":[{"given":"E.","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De la Cruz-Puebla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Painous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"\u00c1lvarez-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Dicaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rodr\u00edguez-Revenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zuchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.501924_bib0150","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.2007.126284","article-title":"Downbeat nystagmus: aetiology and comorbidity in 117 patients","volume":"79","author":"Wagner","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2026.501924_bib0155","doi-asserted-by":"crossref","first-page":"e105463","DOI":"10.1371\/journal.pone.0105463","article-title":"The gait disorder in downbeat nystagmus syndrome","volume":"9","author":"Schniepp","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nrleng.2026.501924_bib0160","doi-asserted-by":"crossref","first-page":"e0168808","DOI":"10.1371\/journal.pone.0168808","article-title":"Postural ataxia in cerebellar downbeat nystagmus: its relation to visual, proprioceptive and vestibular signals and cerebellar atrophy","volume":"12","author":"Helmchen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nrleng.2026.501924_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/01.wnl.0000194242.28018.d9","article-title":"Detection of floccular hypometabolism in downbeat nystagmus by fMRI","volume":"66","author":"Kalla","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501924_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12311-020-01113-x","article-title":"A variation in FGF14 is associated with downbeat nystagmus in a genome-wide association study","volume":"19","author":"Strupp","year":"2020","journal-title":"Cerebellum"},{"key":"10.1016\/j.nrleng.2026.501924_bib0175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa2207406","article-title":"Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia","volume":"388","author":"Pellerin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2026.501924_bib0180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajhg.2022.11.015","article-title":"An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50\/ATX-FGF14","volume":"110","author":"Rafehi","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nrleng.2026.501924_bib0185","doi-asserted-by":"crossref","first-page":"105076","DOI":"10.1016\/j.ebiom.2024.105076","article-title":"Intronic FGF14 GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment response","volume":"102","author":"Pellerin","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nrleng.2026.501924_bib0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/WNF.0b013e31825a68c5","article-title":"The use of AP in neurological disorders","volume":"35","author":"Sedehizadeh","year":"2012","journal-title":"Clin Neuropharm"},{"key":"10.1016\/j.nrleng.2026.501924_bib0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/CPJ.0000000000000321","article-title":"Aminopyridines for the treatment of neurologic disorders","volume":"7","author":"Strupp","year":"2017","journal-title":"Neurol Clinic Pract"},{"key":"10.1016\/j.nrleng.2026.501924_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1352458506069538","article-title":"Fampridine-SR in multiple sclerosis: a randomized, doubleblind, placebo-controlled, dose-ranging study","volume":"13","author":"Goodman","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.nrleng.2026.501924_bib0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","article-title":"Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study","volume":"61","author":"Strupp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501924_bib0210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/01.WNL.0000118287.68294.E5","article-title":"4-Aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain","volume":"62","author":"Kalla","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501924_bib0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1325.037","article-title":"Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus","volume":"1039","author":"Sprenger","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nrleng.2026.501924_bib0220","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/WNO.0b013e3182258086","article-title":"Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus","volume":"31","author":"Kalla","year":"2011","journal-title":"J Neuro-Ophthalmol"},{"key":"10.1016\/j.nrleng.2026.501924_bib0225","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1007\/s00415-013-6911-5","article-title":"Dalfampridine in patients with downbeat nystagmus: an observational study","volume":"260","author":"Claassen","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501924_bib0230","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","article-title":"A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias","volume":"77","author":"Strupp","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501924_bib0235","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00415-012-6764-3","article-title":"Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study","volume":"260","author":"Claassen","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501924_bib0240","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00415-013-7029-5","article-title":"Experience in a short-term trial with 4-aminopyridine in cerebellar ataxia","volume":"260","author":"Giordano","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501924_bib0245","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1093\/brain\/awad157","article-title":"GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response","volume":"146","author":"Wilke","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501924_bib0250","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1007\/s00415-023-11868-y","article-title":"4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience","volume":"270","author":"Seemann","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501924_bib0255","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.1038\/s41598-023-36654-8","article-title":"Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia\/spinocerebellar ataxia 27B","volume":"13","author":"Bonnet","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2026.501924_bib0260","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","author":"Jen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501924_bib0265","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad239","article-title":"Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients","volume":"5","author":"Ashton","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.nrleng.2026.501924_bib0270","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1523\/JNEUROSCI.2663-14.2015","article-title":"Intracellular FGF14 (iFGF14) is required for spontaneous and evoked firing in cerebellar Purkinje neurons and for motor coordination and balance","volume":"35","author":"Bosch","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.nrleng.2026.501924_bib0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002210100788","article-title":"Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells","volume":"139","author":"Etzion","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.nrleng.2026.501924_bib0280","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1523\/JNEUROSCI.3582-09.2010","article-title":"The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia","volume":"30","author":"Alvina","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.nrleng.2026.501924_bib0285","doi-asserted-by":"crossref","first-page":"11795","DOI":"10.1523\/JNEUROSCI.0905-11.2011","article-title":"Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1","volume":"31","author":"Hourez","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.nrleng.2026.501924_bib0290","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cmpb.2013.11.008","article-title":"Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine","volume":"113","author":"Abbasi","year":"2014","journal-title":"Comput Methods Programs Biomed"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:24:57Z","timestamp":1793622297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580826000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2173580826000313"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501924","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501924"}}